/Investor DB

Benchstrength Partners — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

Altisaltis.vcJun 2023

Altis provides independent, IC-grade investment diligence and market research on private companies from Seed to Series D+, working outside-in without access to management or data rooms.

AI & Machine LearningData & InfrastructureFintech

Co-investorsPrimary Venture PartnersDebiopharm Innovation FundGalapagos Capital

Altis Labsaltislabs.comin𝕏Jun 2023

Altis Labs provides a web-based platform that applies AI models to medical imaging data to generate reproducible predictions and quantifications for clinical trials.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesToronto, CA

Felix Baldauf-Lenschen(Founder & CEO)inJohn(CTO)

Co-investorsCreative Destruction Lab (CDL)Debiopharm Innovation FundFusionOrbiMed

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.